Fosun plans $800m Henlius Biotech spin-off
Shanghai Henlius Biotech has joined a growing pipeline of biotechnology firms planning to float in Hong Kong. It wants to list in the first quarter of 2019, said a banker working on the transaction.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: